Madelon M E de Jong
7PUBLICATIONS
55CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Dec 18, 2025
Circulating tumor cells in myeloma are a compound biomarker for bone marrow high-risk genomic alterations and tumor load.Cathelijne Fokkema, Luca Bertamini, Madelon M E de Jong
|Feb 28, 2025
The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy.Charlotte L B M Korst, Sabrin Tahri, Carolien Duetz
|Apr 10, 2024
An IL-1β-driven neutrophil-stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma.Madelon M E de Jong, Cathelijne Fokkema, Natalie Papazian
|Mar 16, 2024
Bone marrow inflammation in haematological malignancies.Madelon M E de Jong, Lanpeng Chen, Marc H G P Raaijmakers
|Jul 20, 2023
A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML.Lanpeng Chen, Eline Pronk, Claire van Dijk
Pageof 2
Frequent Collaborators
3 joint publications
Pieter Sonneveld
3 joint publications
Mathijs Arnoud Sanders
3 joint publications
Tom Cupedo
2 joint publications
Sabrin Tahri
2 joint publications
Vincent H J van der Velden
2 joint publications
Cathelijne Fokkema
2 joint publications
Gregory van Beek
1 joint publications
Joke Zink
1 joint publications
Emma de Pater
1 joint publications
Lanpeng Chen
